Authors:
KULSKI JK
SADLEIR JW
KELSALL SR
CICCHINI MS
SHELLAM G
PENG SW
QI YM
GALLOWAY DA
ZHOU J
FRAZER IH
Citation: Jk. Kulski et al., TYPE-SPECIFIC AND GENOTYPE CROSS-REACTIVE B-EPITOPES OF THE L1 PROTEIN OF HPV16 DEFINED BY A PANEL OF MONOCLONAL-ANTIBODIES, Virology, 243(2), 1998, pp. 275-282
Citation: J. Xiang et al., INHIBITION OF ESTABLISHED TUMOR-GROWTH IN SYNGENEIC MICE BY LOCAL INOCULATION OF ENGINEERED MOUSE MYELOMA CELLS SECRETING A RECOMBINANT FUSION PROTEIN RM4 TNF/, Cancer gene therapy, 4(6), 1997, pp. 353-358
Citation: Xa. Jim et al., INHIBITION OF ESTABLISHED TUMOR-GROWTH IN SYNGENEIC MICE BY VACCINATION OF ENGINEERED MOUSE MYELOMA CELLS SECRETING A FUSION PROTEIN RM4 TNF/, The FASEB journal, 11(3), 1997, pp. 3150-3150
Citation: J. Xiang et al., GENETIC-ENGINEERING OF A RECOMBINANT FUSION POSSESSING ANTITUMOR F(AB')(2) AND TUMOR-NECROSIS-FACTOR, Journal of biotechnology, 53(1), 1997, pp. 3-12
Authors:
EVANDER M
FRAZER IH
PAYNE E
QI YM
HENGST K
MCMILLAN NAJ
Citation: M. Evander et al., IDENTIFICATION OF THE ALPHA(6) INTEGRIN AS A CANDIDATE RECEPTOR FOR PAPILLOMAVIRUSES, Journal of virology, 71(3), 1997, pp. 2449-2456
Authors:
XIANG J
MOYANA T
MATTE G
WILKINSON A
ITZKOWITZ S
QI YM
Citation: J. Xiang et al., ESTABLISHMENT OF A RAT COLONIC-CARCINOMA MODEL FOR STUDY OF IMMUNOREAGENTS AGAINST THE HUMAN TUMOR-ASSOCIATED TAG72 ANTIGEN, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(5), 1996, pp. 335-344
Citation: Ym. Qi et al., MOUSE MYELOMA CELL-LINE SECRETING BIFUNCTIONAL FUSION PROTEIN RM4 IFN-TAU ELICITS ANTITUMOR CD8 MHC CLASS I-RESTRICTED T-CELLS THAT ARE CYTOLYTIC IN-VITRO AND TUMORICIDAL IN-VIVO/, Journal of interferon & cytokine research, 16(10), 1996, pp. 771-776
Citation: Ym. Qi et al., EVALUATION OF A SIMPLE PROTEIN-FREE MEDIUM THAT SUPPORTS HIGH-LEVELS OF MONOCLONAL-ANTIBODY PRODUCTION, Cytotechnology, 21(2), 1996, pp. 95-109
Authors:
QI YM
PENG SW
HENGST K
EVANDER M
PARK DS
ZHOU J
FRAZER IH
Citation: Ym. Qi et al., EPITHELIAL-CELLS DISPLAY SEPARATE RECEPTORS FOR PAPILLOMAVIRUS VLPS AND FOR SOLUBLE L1 CAPSID PROTEIN, Virology, 216(1), 1996, pp. 35-45
Authors:
QI YM
MOYANA T
MATTE G
WILKINSON A
BRESALIER R
XIANG J
Citation: Ym. Qi et al., IMMUNOLOCALIZATION OF HEPATIC METASTASES OF HUMAN COLONIC-CANCER BY CHIMERIC ANTI-TAG72 ANTIBODY IN SCID MICE, Journal of surgical oncology, 59(1), 1995, pp. 3-9
Citation: Ym. Qi et al., ANTIBODY-TARGETED LYMPHOKINE-ACTIVATED KILLER-CELLS INHIBIT LIVER MICROMETASTASES IN SEVERE COMBINED IMMUNODEFICIENT MICE, Gastroenterology, 109(6), 1995, pp. 1950-1957
Citation: J. Xiang et al., SINGLE-CHAIN ANTIBODY VARIABLE REGION-TARGETED INTERLEUKIN-2 STIMULATES T-CELL KILLING OF HUMAN COLORECTAL-CARCINOMA CELLS, Immunology and cell biology, 72(4), 1994, pp. 275-285
Citation: Tn. Moyana et al., DEVELOPMENT OF THE EARLY MUCOSAL LESIONS IN EXPERIMENTAL INFLAMMATORYBOWEL-DISEASE - IMPLICATIONS FOR PATHOGENESIS, Experimental and molecular pathology, 60(2), 1994, pp. 119-129
Citation: J. Xiang et al., RECOMBINANT BIFUNCTIONAL MOLECULE FV IFN-GAMMA POSSESSES THE ANTITUMOR FV AS WELL AS THE GAMMA-INTERFERON ACTIVITIES/, Cancer biotherapy, 8(4), 1993, pp. 327-337
Authors:
XIANG J
LIU EW
DELBAERE LTJ
CHEN ZN
LUO XM
QI YM
RATHGEBER C
Citation: J. Xiang et al., THE TYROSINE RESIDUE AT POSITION-97 IN THE V(H)-CDR3-REGION OF A MOUSE-HUMAN CHIMERIC ANTI-COLORECTAL CARCINOMA ANTIBODY CONTRIBUTES HYDROGEN-BONDING TO THE TAG72-ANTIGEN, Cancer biotherapy, 8(3), 1993, pp. 253-262
Citation: Ym. Qi et al., HIGH-AFFINITY CHIMERIC ANTI-(COLORECTAL CARCINOMA) ANTIBODY CORRELATED TO ENHANCED TUMOR TARGETING IN BIODISTRIBUTION AND IMAGING, Journal of cancer research and clinical oncology, 120(1-2), 1993, pp. 57-62